Please use this identifier to cite or link to this item:
https://ninho.inca.gov.br/jspui/handle/123456789/6870
Title: | ()-3,4-Dihydroxy-8,9-methylenedioxypterocarpan and derivatives: Cytotoxic effect on human leukemia cell lines |
Authors: | Daher Netto, Chaquip Castro, Carolina Pereira Santos, Eduardo Salustiano Jesus dos Silva, Alcides José Monteiro da Rumjanek, Vivian Mary Barral Dodd Costa, Paulo Roberto Ribeiro |
Keywords: | Pterocarpanos Pterocarpans Citotoxinas Cytotoxins Fenotipo Fenótipo Phenotype Leucemia Leukemia Quinonas Quinones |
Issue Date: | 2009 |
Publisher: | European Journal of Medicinal Chemistry |
Citation: | DAHER NETTO, Chaquip et al. ()-3,4-Dihydroxy-8,9-methylenedioxypterocarpan and derivatives: Cytotoxic effect on human leukemia cell lines. European Journal of Medicinal Chemistry, v. 44, p. 920-925, 2009. |
Abstract: | Naturally occurring pterocarpans 1a,b, pterocarpan 1c, isoflavane 2 and ortho-quinone 3 were synthesized in the racemic form and their cytotoxic effect was evaluated on the human leukemia cell lines K562 (resistant to oxidative stress), Lucena-1 (MDR phenotype) and HL-60. Ortho-quinone 3 (IC50 ¼ 1.5 mM, 1.8 mM and 0.2 mM, respectively) and catechol pterocarpan 1a (IC50 ¼ 3.0 mM, 3.7 mM and 2.1 mM, respectively) were the most active compounds on these cells and were also evaluated on other human leukemia cell lines (Jurkat and Daudi). Orthoquinone 3 was 2 to 10 times more potent than pterocarpan 1a, depending on the cell line considered, however, showed a greater toxicity for lymphocytes activated by PHA. |
Description: | p. 920-925.: il, p&b. |
URI: | http://sr-vmlxaph03:8080/jspui/handle/123456789/6870 |
Appears in Collections: | Artigos de Periódicos da área de Farmácia |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
(±)-3,4-Dihydroxy-8,9-methylenedioxypterocarpan and derivatives Cytotoxic effect on human leukemia cell lines.pdf | 272.99 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.